Podcast Episodes

529s for 5/29

On May 29, there is one investing account that deserves a celebration.

First up, (00:21) Ricky Mulvey and Bill Barker break down earnings from Chewy, …

2 years ago

Activists: Higher All-Time Highs, Please

Sometimes, great isn’t good enough.

(00:21) Jason Moser and Mary Long discuss T-Mobile’s latest purchase and why Elliott Management has beef with a co…

2 years ago

Finding “Home Run” Investments

Venture capitalists don’t mind strike-outs, so long as they get their home runs. What can stock investors learn from that approach? 

Ricky Mulvey talk…

2 years ago

The Movies’ Market Correction

In 2018, the U.S. box office grossed almost $12 billion. This year, it’s expected to bring in closer to $8 billion. What’s eating the silver screen?

C…

2 years ago

Nvidia, Target & The Mailbag

AI continues to float Nvidia’s boat, and it's helping an unlikely old school name in tech.

(00:21) Jason Moser and Bill Mann discuss:

- Nvidia’s blowou…

2 years ago

Nvidia Rolls On

The tech giant continues to crush analysts’ lofty expectations.

(00:20) Asit Sharma joins Ricky Mulvey to discuss the boom of Nvidia’s data center bus…

2 years ago

Tight Budgets Come for Target

Just how resilient is resilient?

(00:21) Jason Moser and Mary Long take a look at Target earnings, the “resilient consumer,” and new rules for the Buy…

2 years ago

What's on Jamie Dimon's Mind?

A lot, actually.

(00:21) Bill Mann and Ricky Mulvey discuss JPMorgan’s investor day and CEO Jamie Dimon’s thoughts on stock buybacks and inflation. Th…

2 years ago

A New Name in Weight-Loss Drugs

Novo Nordisk and Eli Lilly have soared on GLP-1 weight-loss drugs – now Hims & Hers is trying to get in on the action with a more available and affor…

2 years ago

Better Investment: Stocks or Real Estate?

So, you want to grow your wealth. What’s the best way to do it?

In this special episode of Motley Fool Money, we team up with our friends at the real-…

2 years ago